Nitric Oxide
| A |
Endothelium |
|
| B |
RBC |
|
| C |
Platelets |
|
| D |
Lymphocytes |
| A |
Endothelium |
|
| B |
RBC |
|
| C |
Platelets |
|
| D |
Lymphocytes |
Endothelium REF: Guyton’s physiology 22nd edition page 199
Nitric oxide should not be confused with nitrous oxide (N20), an anesthetic and greenhouse gas, or with nitrogen dioxide (NO2), a brown toxic gas and a major air pollutant.
Nitric oxide, known as the ‘endothelium-derived relaxing factor’, or `EDRF’, is biosynthesized endogenously from L-arginine, oxygen and NADPH by various nitric oxide synthase (NOS) enzymes. Reduction of inorganic nitrate may also serve to make nitric oxide. The endothelium (inner lining) of blood vessels uses nitric oxide to signal the surrounding smooth muscle to relax, thus resulting in vasodilation and increasing blood flow.
All are true about nitric oxide except
| A |
Acts through cAMP |
|
| B |
Helps to regulate vascular tone |
|
| C |
Important role in penile erection |
|
| D |
Present in low concentration in cigarette smokers |
All are true about nitric oxide except
| A |
Acts through cAMP |
|
| B |
Helps to regulate vascular tone |
|
| C |
Important role in penile erection |
|
| D |
Present in low concentration in cigarette smokers |
Acts through cAMP [Ref: Ganong 22/e p598; http://hyperahajournols.org/cgi/content/abstract/35/6/1237; hup://www. trdrp.org/research/PageGrant.asp?grimt_id=1550]
- Nitric oxide acts through cGMP.
- Nitric oxide (NO) is an important signaling molecule that acts in many tissues to regulate a diverse range of physiological and cellular processes. Its role was first discovered by several groups who were attempting to identify the agent responsible for promoting blood vessel relaxation and regulating vascular tone. This agent was termed endothelium-derived relaxing factor (EDRF), and was later known to be nitric oxide.
Nitric Oxide Synthesis
- Nitric oxide is produced by a group of enzymes called nitric oxide synthases. These enzymes convert arginine into citrulline, producing NO in the process. Oxygen and NADPH are necessary co-factors
Biological Role
- Nitric oxide is a short-lived, highly reactive molecule (with a half-life of a few seconds) These attributes make nitric oxide ideal for a transient signal molecule between adjacent cells and within cells.
- Nitric oxide, acts by stimulating the production of cyclic GMP.
- Nitric oxide has been demonstrated to play a role in a variety of biological processes including neurotransmission, immune defence, the regulation of cell death (apoptosis) and cell motility.
- Nitric oxide has been suggested to play an anti-inflammatory role by inhibiting the expression of the genes for inflammatory cytokines.
- NO has important role in producing penile erection by causing vasodilation and hence engorgement of corpora cavernosa.( Erection is caused by parasympathetic impulses that pass from sacral portion of spinal cord.
- These parasympathetic nerve fibres in contrast to most other parasympathetic fibres are believed to secrete nitric oxide and/or vasoactive intestinal peptide in addition to acetylcholine.)
Sildenafil, popularly known by the trade name Viagra, stimulates erections primarily by enhancing signaling through the nitric oxide pathway in the penis.
- Recent studies have provided important information on the use of inhaled nitric oxide for the management of several diseases characterized by the presence of abnormal pulmonary vascular tone, such as persistent pulmonary hypertension of the newborn.
- Cigarette smoking decreases endogenous NO formation and hence increases the risk of cardiovascular disease through increased hypertension and platelet aggregation.
Nitric Oxide (NO) is a novel neurotransmitter which is condidered to have an effect in the pathophysiology of which of the folowing psychiatric conditions?
| A |
Substance Misuse |
|
| B |
Mood Disorders |
|
| C |
Schizophrenia |
|
| D |
OCD |
Nitric Oxide (NO) is a novel neurotransmitter which is condidered to have an effect in the pathophysiology of which of the folowing psychiatric conditions?
| A |
Substance Misuse |
|
| B |
Mood Disorders |
|
| C |
Schizophrenia |
|
| D |
OCD |
Nitric oxide is a neuro transmitter, in the gaseous for which is considered to have an effect in mood disorders. NOS expressing neurons are well represented in the areas implicated in depression. SSRIs is thought to directly inhibit NOS activity.
Ref: Kaplan and Sadock, 10th Edition.
Nitric oxide is synthesised from:
| A |
Cysteine |
|
| B |
Cystine |
|
| C |
Methionine |
|
| D |
Arginine |
Nitric oxide is synthesised from:
| A |
Cysteine |
|
| B |
Cystine |
|
| C |
Methionine |
|
| D |
Arginine |
Which of the following is an important mediator of vasodilation?
| A |
Nitric oxide |
|
| B |
Oxygen |
|
| C |
Leukotriene |
|
| D |
All of the above |
Which of the following is an important mediator of vasodilation?
| A |
Nitric oxide |
|
| B |
Oxygen |
|
| C |
Leukotriene |
|
| D |
All of the above |
Ref: Robbins 8th edition, Chapter 2.
The primary action of the neurotransmitter Nitric oxide (NO) in the gastrointestinal tract is:
| A |
Vasodilatation |
|
| B |
Vasoconstriction |
|
| C |
Gastrointestinal smooth muscle relaxation |
|
| D |
Gastrointestinal slow smooth muscle contraction |
The primary action of the neurotransmitter Nitric oxide (NO) in the gastrointestinal tract is:
| A |
Vasodilatation |
|
| B |
Vasoconstriction |
|
| C |
Gastrointestinal smooth muscle relaxation |
|
| D |
Gastrointestinal slow smooth muscle contraction |
Which of the following regulators would MOST likely inhibit the lower esophageal sphincter in normal individuals?
| A |
Acetylcholine and substance P |
|
| B |
Substance P and nitric oxide |
|
| C |
Substance P only |
|
| D |
Vasoactive intestinal polypeptide and nitric oxide |
Which of the following regulators would MOST likely inhibit the lower esophageal sphincter in normal individuals?
| A |
Acetylcholine and substance P |
|
| B |
Substance P and nitric oxide |
|
| C |
Substance P only |
|
| D |
Vasoactive intestinal polypeptide and nitric oxide |
Nitric oxide is a potent vasodilator. Where is it produced from?
| A |
Endothelium |
|
| B |
RBC |
|
| C |
Platelets |
|
| D |
Lymphocytes |
Nitric oxide is a potent vasodilator. Where is it produced from?
| A |
Endothelium |
|
| B |
RBC |
|
| C |
Platelets |
|
| D |
Lymphocytes |
Nitric oxide, known as the ‘endothelium-derived relaxing factor’, or ‘EDRF’. Endothelial cells contain the constitutive form of nitric oxide synthase, which produces moderate amounts of nitric oxide by metabolizing L-arginine. The endothelium of blood vessels uses nitric oxide to signal the surrounding smooth muscle to relax, thus resulting in vasodilation and increasing blood flow.
Functions: Endothelium-derived nitric oxide inhibits contraction and proliferation of the underlying vascular smooth muscle, adhesion of blood cells and platelets, and platelet aggregation.
Ref: Hypertension Primer: The Essentials of High Blood Pressure By Joseph L Izzo, Jr, Henry R Black, M.D., Theodore L. Goodfriend, 2003, Page 44; Guyton’s physiology, 22nd edition, Page 199
Which of the following is an endothelial smooth muscle relaxing factor?
| A |
Nitric oxide |
|
| B |
Angiotensin |
|
| C |
Dopamine |
|
| D |
Vasopressin |
Which of the following is an endothelial smooth muscle relaxing factor?
| A |
Nitric oxide |
|
| B |
Angiotensin |
|
| C |
Dopamine |
|
| D |
Vasopressin |
Nitric oxide acts in paracrine manner on target cells through induction of cGMP which in turn initiates a series of intravascular events leading to relaxation of vascular smooth muscle.
Nitric Oxide is produced in:
| A |
Endothelium |
|
| B |
Plasma |
|
| C |
Platelets |
|
| D |
Serum |
Nitric Oxide is produced in:
| A |
Endothelium |
|
| B |
Plasma |
|
| C |
Platelets |
|
| D |
Serum |
A i.e. Endothelium
Nitric oxide is synthesized from arginine by the enzyme NO synthetase (NOS) in endothelial cellsQ. It causes vasodilation.
Regarding nitric oxide false is
| A |
Derived from endothelium |
|
| B |
Acts by increasing c-AMP levels |
|
| C |
Vasodilator |
|
| D |
Derived from arginine |
Regarding nitric oxide false is
| A |
Derived from endothelium |
|
| B |
Acts by increasing c-AMP levels |
|
| C |
Vasodilator |
|
| D |
Derived from arginine |
B i.e. Acts by increasing C- AMP level
True statement regarding Nitric oxide is :
| A |
NO is synthesized from arginine |
|
| B |
NO is spontaneous produced from NO2 |
|
| C |
NO causes vasoconstriction |
|
| D |
NO is released from mitochondria |
True statement regarding Nitric oxide is :
| A |
NO is synthesized from arginine |
|
| B |
NO is spontaneous produced from NO2 |
|
| C |
NO causes vasoconstriction |
|
| D |
NO is released from mitochondria |
A i.e. NO is synthesized from arginine
True about nitric oxide:
| A |
Free radical |
|
| B |
Vasodilator |
|
| C |
Oxidizing agent |
|
| D |
All |
True about nitric oxide:
| A |
Free radical |
|
| B |
Vasodilator |
|
| C |
Oxidizing agent |
|
| D |
All |
A i.e. Free radical; B i.e. Vasodilator; C i.e. Oxidizing agent
Drugs which increases nitric oxide are all except‑
| A |
Glycerine trinitrate |
|
| B |
Hydralazine |
|
| C |
Sodium nitroprusside |
|
| D |
Fenoldopam |
Drugs which increases nitric oxide are all except‑
| A |
Glycerine trinitrate |
|
| B |
Hydralazine |
|
| C |
Sodium nitroprusside |
|
| D |
Fenoldopam |
Ans. is ‘d’ i.e., Fenoldopam
o NO donors, which release NO are used to elicit smooth muscle relaxation. Drugs are –
1. Organic nitrates (nitroglycerine) 3. Sodium nitroprusside 5. Nebivolol
2. Organic nitrites (Isoamylnitrite) 4. Hydralazine
Inhaled nitric oxide is used –
| A |
For stabilizing systemic heamodynamics |
|
| B |
In case of jaundice |
|
| C |
To prevent CNS complication |
|
| D |
For reducing pulmonary hypertension |
Inhaled nitric oxide is used –
| A |
For stabilizing systemic heamodynamics |
|
| B |
In case of jaundice |
|
| C |
To prevent CNS complication |
|
| D |
For reducing pulmonary hypertension |
Ans. is ‘d’ i.e., For reducing pulmonary hypertension
According to Goodman Gilman
“Inhaled nitric oxide has been approved by FDA for use in newborns with persistent pulmonary hypertension and has become the first line therapy for this disease. In this disease state NO inhalation has been shown to reduce, significantly, the necessity for extracorporeal oxygenation”
The only FDA approved application of nitric oxide is ?
| A |
Primary pulmonary hypertension |
|
| B |
Newborn with pulmonary hypertension |
|
| C |
Congestive cardiac failure |
|
| D |
HAPE |
The only FDA approved application of nitric oxide is ?
| A |
Primary pulmonary hypertension |
|
| B |
Newborn with pulmonary hypertension |
|
| C |
Congestive cardiac failure |
|
| D |
HAPE |
Ans. is ‘b’ i.e., Newborn with pulmonary hypertension
True about nitric oxide
| A |
Formed from L-Arginine by NO synthase |
|
| B |
Causes vasodilation in all vessels |
|
| C |
Used in portal hypertension |
|
| D |
All |
True about nitric oxide
| A |
Formed from L-Arginine by NO synthase |
|
| B |
Causes vasodilation in all vessels |
|
| C |
Used in portal hypertension |
|
| D |
All |
A i.e. Formed from L-arginine by NO Synthetase; B i.e. Causes vasodilation of all vessels; C i.e. Used in portal hypertension
Which of the following statements is true regarding Nitric oxide:
| A |
Used in pulmonary hypertension |
|
| B |
Decreases the dose of anaesthetics |
|
| C |
Sympathomimetic action |
|
| D |
b and c |
Which of the following statements is true regarding Nitric oxide:
| A |
Used in pulmonary hypertension |
|
| B |
Decreases the dose of anaesthetics |
|
| C |
Sympathomimetic action |
|
| D |
b and c |
A i.e. Used in pulmonary hypertension
True about inhaled nitric oxide
| A |
Causes generalized (systemic) vasodilation |
|
| B |
Dilates pulmonary arteries |
|
| C |
Causes hypotension, increase pulmonary artery pressure |
|
| D |
All |
True about inhaled nitric oxide
| A |
Causes generalized (systemic) vasodilation |
|
| B |
Dilates pulmonary arteries |
|
| C |
Causes hypotension, increase pulmonary artery pressure |
|
| D |
All |
B i.e, Dilates pulmonary arteries
Which of the following inhaled gas is used to decrease pulmonary artery pressure in adults and infants?
| A |
Nitrous oxide |
|
| B |
Nitrogen dioxide |
|
| C |
Nitric oxide |
|
| D |
Nitrogen |
Which of the following inhaled gas is used to decrease pulmonary artery pressure in adults and infants?
| A |
Nitrous oxide |
|
| B |
Nitrogen dioxide |
|
| C |
Nitric oxide |
|
| D |
Nitrogen |
C i.e. Nitric oxide
Nitric oxide (NO) or endothelium derived relaxing factor (EDRF) is synthesized from L-arginine by nitric oxide synthase (NOS) enzyme in endothelium of blood vesselsQ. Physiologically it causes vasodilation & decreases vascular resistance throughout the bodyQ. It activates guanylyl cyclase producing C-GMP and binds rapidly to Hb & gets inactivatedQ.
Whereas inhaled NO is a selective pulmonary-vasodilator decreases pulmonary artery pressure in infants & adults and improves V/P ratioQ. So it is used in treatment of pulmonary artery hypertensionQ. It has no systemic vasodilatory effectQ. Systemic effects of breathing NO includes platetlet & leukocyte inhibition and oxidation of extraerythrocytic hemoglobin.
Inhaled NO decreases vascular smooth muscle cell hyperplasia & increases alveolarization in the injured developing limb. This pulmonary vascular & alveolar developmental effect of NO is used to prevent or ameliorate pulmonary hypertension in infants with congenital heart disease and chronic lung disease in premature infants.
Which of the following inflammatory mediator doesn’t cause fever:
| A |
Nitric oxide |
|
| B |
Prostaglandin |
|
| C |
IL-1 |
|
| D |
TNF-alpha |
Which of the following inflammatory mediator doesn’t cause fever:
| A |
Nitric oxide |
|
| B |
Prostaglandin |
|
| C |
IL-1 |
|
| D |
TNF-alpha |
Pyrogens
- A pyrogen is a substance that induces fever.
- These can be either internal (endogenous) or external (exogenous) to the body.
- The bacterial substance lipopolysaccharide (LPS), present in the cell wall of some bacteria, is an example of an exogenous pyrogen.
- Endogenous Pyrogens
- IL 1
- TNF
- PGs
- Depyrogenation may be achieved through filtration, distillation, chromatography, or inactivation.
Platelet adhesion is inhibited by ‑
| A |
Nitric oxide |
|
| B |
Substance P |
|
| C |
Thrombin |
|
| D |
IL 2 |
Platelet adhesion is inhibited by ‑
| A |
Nitric oxide |
|
| B |
Substance P |
|
| C |
Thrombin |
|
| D |
IL 2 |
Ans. is ‘a’ i.e., Nitric Oxide
Nitric oxide is derived from which amino acid‑
| A |
Histidine |
|
| B |
Lysine |
|
| C |
Methionine |
|
| D |
Arginine |
Nitric oxide is derived from which amino acid‑
| A |
Histidine |
|
| B |
Lysine |
|
| C |
Methionine |
|
| D |
Arginine |
Ans:D.)Arginine.
NITRIC OXIDE (NO)/ENDOTHELIUM DERIVED RELAXING FACTOR (EDRF)
- Nitric oxide, a vasodilator is formed by the action of nitric oxide synthase on Arginine. Synthesis:
- NO is formed by the action of Cytosolic enzyme NO synthase in endothelial & neuronal cells.
- Substrate: Arginine, O 2 , NADPH
- Coenzyme: NADPH, FAD, FMN, Heme, tetrahydrobiopterin
- Product: Citrulline, NO
Features
- Reacts with oxygen & superoxide ïƒ peroxynitrite which decomposes to form highly reactive OH-radical
- It stimulates guanyl cyclase (cGMP)
Functions
- Relaxes smooth muscles
- Prevents platelet aggregation
- Functions as neurotransmitter in brain
- Mediates tumoricidal, bactericidal actions of macrophages
- Involved in penile erection; (sildenafil affects this process by inhibiting a cGMP dependent phosphodiesterase)



